X0508 4 2025-09-16 0 0001962011 Kairos Pharma, LTD. KAPA 0001988551 Bae Hyun W. C/O KAIROS PHARMA, LTD. 2355 WESTWOOD BLVD, #139 LOS ANGELES CA 90064 1 0 0 0 0 COMMON STOCK 2025-09-16 4 A 0 10000 0.00 A 54286 D COMMON STOCK 2025-10-08 4 A 0 19084 0.00 A 73370 D Represents 10,000 restricted stock units ("RSUs") issued to the Reporting Person under the Kairos Pharma, Ltd. 2023 Equity Incentive Plan (the "Plan"). The 10,000 RSUs were granted on September 16, 2024, in conjunction with the Issuer's initial public offering (IPO), and vest annually in three substantially equal installments commencing on the anniversary date of the IPO. Consists of (i) 47,620 shares of common stock and (ii) 6,666 RSUs which remain subject to vesting. Represents 19,084 RSUs issued to the Reporting Person under the Plan. The 19,084 RSUs are scheduled to vest in full on the first anniversary of the grant date. Consists of (i) 54,286 shares of common stock and (ii) 19,084 RSUs which remain subject to vesting. /s/ Hyun W. Bae 2025-12-23